Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

Amycretin also improved participants’ blood sugar levels in positive sign for Danish company’s treatment pipeline ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

A study of 6,800 colon cancer patients found those who took Ozempic or Mounjaro were more likely to survive the disease. It ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

It’s one of the more surprising side effects being discussed online: a wave of unexpected pregnancies among people taking ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Pharmaceutical company Eli Lilly is looking to roll out a daily weight loss pill for patients with obesity and type 2 ...

Regular injections could soon be a thing of the past for two different ailments, as a new pill arises as an alternative to ...

Researchers said more should be done to weigh the pros and cons of taking weight loss drugs around the time of pregnancy.